Aim: Atherosclerosis is a chronic inflammatory process of the arterial wall and carotid intima-media thickness (cIMT) is regarded as its early marker. Several members of the IL-17 family are involved in pro-inflammatory functions. The specific aim of the study was to explore the relationships of common genetic variants on IL-17 genes with cIMT thickening.
Introduction
Atherosclerosis is one of the major pathologies of cardiovascular diseases (CVDs) 1) . It more frequently occurs in aged subjects, accordingly, the global public health impacts of atherosclerosis will continuously increase with the elongation of life expectancy 2) . To
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to detect changes in the blood vessel structures and their ability to predict the most deleterious clinical manifestations myocardial infarction and stroke, carotid intima-media thickness (cIMT) can be detected easily and non-invasively using B-mode carotid ultrasound 3, 4) . In addition to myocardial infarction and stroke [5] [6] [7] , thicker cIMT has been strongly correlated with cognitive impairments [8] [9] . Currently, cIMT measurement is wildly used to assess the vascular health status of an individual and thicker cIMT is regarded as an intermediate phenotype of atherosclerosis.
Atherosclerosis is a chronic inflammatory process of the arterial wall 10) . Recently, a new T helper cell subset that secrets signature cytokine IL-17 was identified 11) . Several members of the IL-17 family are involved in pro-inflammatory functions 12) . The IL-17 family induces downstream responses through binding with cell surface receptors, e.g., IL-17RC is critical to the binding of IL-17A and IL-17F 13) . Additionally, previous twin studies showed that significant proportions of cIMT variations could be explained by genetic factors [14] [15] [16] . It is reasonable to hypothesize that genetic variants on these IL-17-related genes may also contribute to cIMT thickening. Accordingly, the specific aim of the study was to explore the relationships between common genetic variants in IL-17-related genes and cIMT.
Materials and Methods

Study Design and Study Subjects
We used two case-control studies to explore the influences of common genetic variants on IL-17 genes with cIMT. The study subjects of the discovery study were from a community-based cohort enrolled by the Mitochondria-Aging in Northern Taiwan (MAGNET) study 17) . From September 2010 to May 2012, 1607 residents aged 40-74 years were enrolled. Twentyseven subjects were excluded due to the lack of good quality of recorded carotid ultrasound images, and another 40 subjects who had ever been diagnosed with coronary artery diseases and received cardiac catheterization and cardiovascular stent were also excluded, leaving a total of 1539 middle-aged and elderly participants in the MAGNET study. The 75 th percentile of the distribution of the mean fall-wall IMT of common carotid arteries (CCA) was 0.70 mm 18) . We randomly selected a sample of 284 subjects who had a mean CCA IMT ≥ 0.70 mm as the cases and selected a sample of 464 subjects who had a mean CCA IMT 0.70 mm as the controls. The study subjects of the validation study were selected from an ongoing community-based cohort from EDTA-containing whole blood samples by a semi-automated extraction system Smart LabAssist (Taiwan Advanced Nanotech Inc., Tau-Yuan County, Taiwan) with TANBead Blood DNA plate (Taiwan Advanced Nanotech Inc.).
We used the Axiom ® CHB 1 Array Plate (Affymetrix Ltd, Santa Clara, CA, USA) Affymetrix Ltd) and the Sequenom iPLEX MassARRAY system (Sequenom, San Diego, CA) to determine the genotypes of study subjects of the discovery and validation studies, respectively. All genotyping were performed by the National Center for Genome Medicine, Academic Sinica, Taiwan.
Statistical Analyses
In the study, we used the student's t and the chisquare tests to compare whether there were significant differences in the anthropometric and laboratory measurements between cases and controls. The chi-square test was also used to compare whether there were significant differences in the frequency distributions of genotypes among groups. The Z test was used to compare the significance of relative frequencies of minor alleles between case and control groups.
The relationships with thicker cIMT for common genetic variants on IL-17 genes were assessed by the additive genotypic effect model. Anthropometric and clinical factors significantly correlated with cIMT were subject to multivariate logistic regression. Assessment of pairwise LD and estimation of haplotype frequencies were performed by Haploview 4.2 software 22) . Adjusted odds ratio (OR) and 95% confidence interval (CI) were calculated by models with and without clinical markers. All statistical analyses were performed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA).
Results
Clinical Characteristics of Study Subjects
In the discovery study, cases had significantly higher means of all, except for HDL-C, anthropometric and laboratory measurements than those of the controls ( Table 1) . The mean level of HDL-C and the proportion of female subjects were significantly lower in the cases than that of the controls. As compared with the controls, the prevalence rates of dyslipidemia, hypertension, and DM were significantly higher in the case group. In the validation study, similar differences in all, except for age, sex, and DM, anthropometric and laboratory measurements between cases and controls were observed.
Among 146 screened SNPs, 12 of them were excluded due to inadequate call rate (n 4), a minor
The cIMT Measurement
The measurement of cIMT was performed according to the protocol recommended by the American Society of Echocardiography 19) and as described previously 18) . In short, two experienced technicians, who were blind to patients' clinical characteristics, obtained and digitally stored both left and right CCA images by using high-resolution B-mode ultrasonography systems (GE Healthcare Vivid 7 and Vivid E9; General Electric Company, Milwaukee, USA), equipped with a multi-frequency linear array transducer. A well-trained technician measured the far wall IMTs blindly by using automatic contouring software (GE Healthcare EchoPAC version 112.0.2; General Electric-Vingmed, Horten, Norway). The IMT was defined as the distance between the lumen-intima and media-adventitia interfaces and included plaques. The average, minimum, and maximum IMTs of the distal 1-2 cm of the left and right CCA were recorded. Mean cIMT was calculated as the mean of the left and right average IMTs and was used for statistical analyses. Our previous study showed that the measurement of cIMT was highly reliable, with intra-class correlation coefficient r greater than 0.97 18) .
SNP Selections
In the discovery study, we used a plate that was designed for the Han Chinese population to screen the relationships of common genetic variants on 11 IL-17-related genes with cIMT. There were 146 SNPs within / 25 Kb of the IL-17A (n 14), IL-17B (n 11), IL-17C (n 3), IL-17D (n 4), IL-17E (n 15), IL-17F (n 18), IL-17RA (n 25), IL-17RB (n 20), IL-17RC (n 2), IL-17RD (n 28), and IL-17RE (n 7) genes. The eligibility of SNPs for association analyses were a call rate 95%, a p-value of Hardy-Weinberg Equilibrium test in the controls 0.001, and a minor allele frequency 5%. For SNPs with a p-value less than the pre-set significance level, calculated as 0.05/146 3.4 10 4 , were regarded as candidate genetic markers and were subjected to validation study.
In addition to the candidate SNP, SNPs that are highly linked with candidate genetic variants and may influence expression and regulation of the associated IL-17 genes were considered for the validation study. The linkage disequilibrium (LD) data in the 1000 Human Genome Project Phase 3-Southern Han Chinese 20) were retrieved by using the Ensemble Genome Browser 21) . The cut-off LD (r 2 ) value of linkage was set at 0.80.
Genotyping
Genomic DNA of each subject was extracted ate-adjusted ORs were 1.462 (95% CI: 1.055-2.027), 1.481 (95% CI: 1.090-2.013), and 1.589 (95% CI: 1.147-2.200), respectively. LD analyses showed that the value of D prime between rs279545 and rs55847610 was 0.96 and was 0.81 for rs279545 with rs3846167. The rs279545 and rs55847610 were grouped as a LD block. We subsequently analyzed the relationship of rs279545-rs55847610 haplotype with the risk of thicker cIMT ( Table 3) . The multivariate-adjusted OR was significantly decreased for A-A haplotype (OR 0.665, 95% CI: 0.487-0.908; p 0.010) and significantly increased for G-G haplotype (OR 1.539, 95% CI: 1.097-2.161; p 0.013).
Discussion
In the present study, we first identified rs279545 of the IL-17RC gene as a promising genetic marker of cIMT thickening and confirmed the finding by subsequent validation study. After adjustment for traditional CVD risk factors, OR of having thicker cIMT for the rs279545-G allele remained significantly increased. In addition to rs279545, two closely linked SNPs rs55847610 and rs3846167 also demonstrating significant correlations with cIMT thickening, which strengthen the validity of ours findings. To our knowlallele frequency of 0.05 (n 3), and significant deviation from Hardy-Weinberg equilibrium (P value of 1 10 3 ; n 5). Among the 134 eligible SNPs for the association analyses, only rs279545 passed the preset significance level of the discovery study and was regarded as candidate genetic marker (Supplementary Table 1 ).
The LD data of the Southern Han Chinese shows that 5 SNPs, including rs3774207, rs55847610, rs59465469, rs55847233, and rs3846167, fitted to the inclusion criteria of the validation study. The rs3774207, rs55847610, rs59465469, and rs55847233 are of the same complete LD block 20) , and among them, rs55847610 is the most suitable for the genotyping platform. Therefore, rs279545, rs55847610, and rs3846167 were included in the validation study (Supplementary Table 2 ).
The test statistics showed that the distributions of the rs279545, rs55847610 and rs3846167 genotypes were significantly different between the case and control groups ( Table 2 ). The minor alleles, i.e., rs279545 G, rs55847610 G, and rs3846167 C, were correlated with higher likelihoods of having thicker cIMT. Further adjustment for age, sex, and traditional CVD risk factors, the estimated ORs of having thicker cIMT changed slightly. The corresponding multivari- was unlikely a genetic marker for cIMT thickening. The role of the rs279545 polymorphism in the regulation and expression of IL-17RC waits for exploration.
Although there was no report exploring the effect of IL-17RC on atherosclerosis, a few human studies had explored the atherogenic effects of IL-17A, the ligand of IL-17RC. Initially, Li et al. (2005) assayed the IL-17 levels in the ischemic hemisphere of the human brain by an immunochemistry method 26) . They found that IL-17 levels were elevated in the ischemic hemispheres of human brains and peaked at days 3-5 after brain ischemia. Furthermore, only very few IL-17-positive cells were observed in the opposite normal hemispheres of human brains 26) . Similarly, several research groups observed IL-17A were expressed in human atherosclerotic lesions [27] [28] [29] [30] [31] and correlated the IL-17A expression levels with the vulnerability of atherosclerotic lesions 28, 29) . On the contrarily, one study reported that IL-17A expression was associated with more stable plaque phenotype rather than macrophage rich plaque areas 32) . In addition to IL-17 expression studies, there were studies compared the frequency of Th17 cells and levels of circulating IL-17 between patients with edge, there was no report correlated genetic polymorphism of IL-17RC with a preclinical CVD marker. Our findings provided potential pathophysiological targets and clinical biomarkers for CVD treatments and predictions.
The indexed SNP rs279545 is located on the genic region of IL-17RC and is a non-coding transcript variant 20) . To date, there were only 2 published reports about its putative functions. The rs279545 was the lead SNP that linked with local adaptation for eastern Asians 23) and was involved in the actin cytoskeleton pathway showing significant association with basal cell carcinoma 24) . To explore possible function related to rs279545 polymorphism, we searched the Taiwan Biobank to identify variants that result in functional change and has a minor allele frequency 3% in the IL-17RC. We found only one missense SNP rs708567 fits the criteria 25) . However, LD data of the Southern Han Chinese showed that this variant was not linked with the rs279545 polymorphism but in complete LD with the rs279590 polymorphism 20) . Notably, the discovery study did not correlate rs279590 polymorphism with cIMT ( Supplementary  Table 1) . Accordingly, the rs708567 polymorphism 
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The authors declare no conflict of interest. atherosclerotic diseases and controls. Most of flow cytometric studies showed that Th17 frequency in peripheral blood, either alone or in relation to T-cell count, was elevated in unstable or more advanced atherosclerosis 28, 29, 32-37) . However, Th17 cell was not found in atherosclerotic tissues 38) and as compared with patients with acute myocardial infarction, the frequency of Th17 cells was significantly higher in patients with stable angina 39) . Similarly, studies of serum or plasma levels of circulating IL-17A and severity or vulnerability of atherosclerosis showed inconsistent results. Most of studies had shown higher levels of circulating IL-17A in subjects with unstable or more advanced plaques [31] [32] [33] [34] [35] [36] . Unexpectedly, a prospective, multicenter study that enrolled acute ST-elevation and non-ST-elevation MI patients found that lower serum IL17 levels correlated with significantly higher risks of all-cause mortality and recurrent MI 40) . Collectively, some human studies suggested that IL-17 may promote the development of atherosclerosis while others pointed to IL-17 as an anti-atherogenic factor. Similarly, studies of isolated cells and animals demonstrated inconsistent findings 41, 42) . The inconsistent findings of different types of studies implicate that the involvement of IL-17 in atherosclerosis is complex. Due to the IL-17 signaling depend on the binding of IL-17s with cell surface receptors IL-17Rs, attempt to explore the effects of IL-17RC variants may help to clarify those discrepancies. Our findings provide a notch for further research.
There were potential limitations of the study. Our pretest showed that high proportion of subjects affected with hyperlipidemia, DM, and hypertension were not able to recall the date of diagnosis and provide information associated with treatments. Therefore, we did not collect these data and were not able to assess the effects of treatments on cIMT in the study. Theoretically, genotypes are not correlated with receiving treatment or not, accordingly, our findings were unlikely results of confounding. Additionally, all study subjects in the discovery and validation studies were restricted to Han Chinese, which may limit the external validity of the study.
In conclusion, we were first to successfully correlate cIMT, a preclinical clinical CVD marker, with IL-17RC, the key molecule in the IL-17 signaling pathway. Our results indicated that IL-17RC may play critical role in the development of atherosclerotic diseases. 
